These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4808509)

  • 21. Fluorometric method for quantitatively estimating urinary dihydroxyphenylethylamine (dopamine), dihydroxyphenylalanine (dopa), and dihydroxyphenylacetic acid (dopac).
    Eichhorn F; Rutenberg A; Kott E
    Clin Chem; 1971 Apr; 17(4):296-300. PubMed ID: 5552365
    [No Abstract]   [Full Text] [Related]  

  • 22. Accelerated synthesis of dopamine in the rat brain after methadone.
    Perez-Cruet J; Di Chiara G; Gessa GL
    Experientia; 1972 Aug; 28(8):926. PubMed ID: 5076326
    [No Abstract]   [Full Text] [Related]  

  • 23. [3H]DOPA formed from [3H]tyrosine in living rat brain is not committed to dopamine synthesis.
    Cumming P; Ase A; Kuwabara H; Gjedde A
    J Cereb Blood Flow Metab; 1998 May; 18(5):491-9. PubMed ID: 9591841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates.
    Ng LK; Colburn RW; Kopin IJ
    J Pharmacol Exp Ther; 1972 Nov; 183(2):316-25. PubMed ID: 5083548
    [No Abstract]   [Full Text] [Related]  

  • 25. Urinary metabolites from rats given L-DOPA.
    Borud O; Midtvedt T; Gjessing LR
    Acta Pharmacol Toxicol (Copenh); 1972; 31(5):540-9. PubMed ID: 4678834
    [No Abstract]   [Full Text] [Related]  

  • 26. [On the formation of H-3-dopa from H-3-tyrosine and determination of the dopa synthesis rate in the fowl and cat adrenal gland under in vivo conditions].
    Hempel K; Männl HF
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(4):391-408. PubMed ID: 4232726
    [No Abstract]   [Full Text] [Related]  

  • 27. Contributions of host and intestinal microflora in the metabolism of L-dopa by the rat.
    Goldin BR; Peppercorn MA; Goldman P
    J Pharmacol Exp Ther; 1973 Jul; 186(1):160-6. PubMed ID: 4723308
    [No Abstract]   [Full Text] [Related]  

  • 28. Metabolism and absorption of L-3,4 dihydroxyphenylalanine in patients with Parkinson's disease.
    Bianchine JR; Calimlim LR; Morgan JP; Dujuvne CA; Lasagna L
    Ann N Y Acad Sci; 1971 Jul; 179():126-40. PubMed ID: 5285373
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolism of dihydroxyphenylalanine and tryptophan in pyridoxine-deficient rats.
    Sourkes TL; Missala K
    Ann N Y Acad Sci; 1969 Sep; 166(1):235-45. PubMed ID: 5262018
    [No Abstract]   [Full Text] [Related]  

  • 30. The formation in vivo of 3,4-dihydroxyphenylalanine (DOPA) from 3-hydroxy-DL-phenylalanine (m-tyrosine).
    Hollunger G; Persson SA
    Acta Pharmacol Toxicol (Copenh); 1974 May; 34(5):391-8. PubMed ID: 4406807
    [No Abstract]   [Full Text] [Related]  

  • 31. Catechol- and indolamines in some endocrine cell systems. An autoradiographical, histochemical and radioimmunological study.
    Tjälve H
    Acta Physiol Scand Suppl; 1971; 360():1-122. PubMed ID: 4933514
    [No Abstract]   [Full Text] [Related]  

  • 32. The conversion of H3-tyrosine to H3-dopa in the adrenal glands under in vivo conditions.
    Hempel K; Männl HF
    Experientia; 1966 Oct; 22(10):689-90. PubMed ID: 5971927
    [No Abstract]   [Full Text] [Related]  

  • 33. Demethylation of 3-O-methyldopa in the kidney: a possible source for dopamine in urine.
    Ibarra FR; Aguirre J; Nowicki S; Barontini M; Arrizurieta EE; Armando I
    Am J Physiol; 1996 May; 270(5 Pt 2):F862-8. PubMed ID: 8928849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro dopamine biosynthesis in the median eminence of rat hypothalamic slices: involvement of voltage-dependent Ca2+ channels.
    Arita J; Kimura F
    Brain Res; 1985 Nov; 347(2):299-305. PubMed ID: 2415215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modification of Parkinsonism--chronic treatment with L-dopa.
    Cotzias GC; Papavasiliou PS; Gellene R
    N Engl J Med; 1969 Feb; 280(7):337-45. PubMed ID: 4178641
    [No Abstract]   [Full Text] [Related]  

  • 36. [Catecholamine metabolism in the tissue of malignant and benign tumors of the sympathetic nervous system].
    Käser H; Türler K; Burri PH
    Schweiz Med Wochenschr; 1971 Apr; 101(13):484-7. PubMed ID: 5558918
    [No Abstract]   [Full Text] [Related]  

  • 37. The metabolic pathways of L-3-O-methyldopa.
    Bartholini G; Kuruma I; Pletscher A
    J Pharmacol Exp Ther; 1972 Oct; 183(1):65-72. PubMed ID: 5080035
    [No Abstract]   [Full Text] [Related]  

  • 38. Determination of DOPA, dopamine, and 5-S-cysteinyl-DOPA in plasma, urine, and tissue samples by high-performance liquid chromatography with electrochemical detection.
    Ito S; Kato T; Maruta K; Fujita K; Kurahashi T
    J Chromatogr; 1984 Nov; 311(1):154-9. PubMed ID: 6440898
    [No Abstract]   [Full Text] [Related]  

  • 39. Enhancement of tyrosine hydroxylation within the brain by chlorpromazine.
    Bartholini G; Pletscher A
    Experientia; 1969 Sep; 25(9):919-20. PubMed ID: 5371411
    [No Abstract]   [Full Text] [Related]  

  • 40. The fate of C14-dihydroxyphenylalanine (C14-dopa) in the whole mouse.
    Wurtman RJ; Chou C; Rose C
    J Pharmacol Exp Ther; 1970 Sep; 174(3):351-6. PubMed ID: 5456168
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.